Sugi Holdings Company Limited operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sugi Holdings Company Limited with three other
companies in this sector in Japan:
Cosmos Pharmaceutical Corp
sales of 502.73 billion Japanese Yen [US$4.49 billion]
Cocokara Fine Incorporated
(377.20 billion Japanese Yen [US$3.37 billion]
of which 99%
was Drug & Dispense), and
Sundrug Co Ltd
(528.39 billion Japanese Yen [US$4.72 billion]
of which 66%
was Drugstore Business).
Sugi Holdings Company Limited reported sales of ¥430.80 billion (US$3.85 billion)
February of 2017.
increase of 3.8%
versus 2016, when the company's sales were ¥414.89 billion.
Sales at Sugi Holdings Company Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 32%).